• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.

作者信息

Lip Gregory Y H

出版信息

Thromb Haemost. 2010 Apr;103(4):683-5. doi: 10.1160/TH10-01-0038. Epub 2010 Feb 2.

DOI:10.1160/TH10-01-0038
PMID:20135056
Abstract
摘要

相似文献

1
Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.抗凝治疗与“中度风险”心房颤动患者的卒中风险[CHADS2评分=1]：简化现实临床实践中的卒中风险评估和血栓预防
Thromb Haemost. 2010 Apr;103(4):683-5. doi: 10.1160/TH10-01-0038. Epub 2010 Feb 2.
2
Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.抗血栓治疗与 CHADS2 评分为 1 的房颤患者的死亡和卒中风险。
Thromb Haemost. 2010 Apr;103(4):833-40. doi: 10.1160/TH09-10-0746. Epub 2010 Feb 2.
3
Atrial fibrillation and anticoagulation.心房颤动与抗凝治疗
Med Health R I. 2001 Mar;84(3):96-7.
4
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.“真实世界”的心房颤动抗栓治疗：EORP-AF 初步调查。
Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.
5
Stroke prevention in atrial fibrillation patients.心房颤动患者的卒中预防。
Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819.
6
[Anticoagulation therapy in paroxysmal atrial fibrillation].[阵发性心房颤动的抗凝治疗]
Tidsskr Nor Laegeforen. 2004 Apr 1;124(7):950-2.
7
[What anticoagulant therapy should be used for what form of atrial fibrillation?].[何种形式的心房颤动应采用何种抗凝治疗？]
Dtsch Med Wochenschr. 2000 Apr 20;125 Suppl 1:S10-1.
8
[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].[心房颤动的抗栓治疗。新推荐及治疗选择的背景]
Lakartidningen. 2008;105(37):2478-80.
9
Cardioembolic stroke: call for a multidisciplinary approach.心源性栓塞性卒中：需要多学科方法。
Cerebrovasc Dis. 2009;27 Suppl 1:82-7. doi: 10.1159/000200444. Epub 2009 Apr 3.
10
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.接受口服抗凝治疗或联合抗血小板治疗的阵发性与持续性心房颤动患者的卒中发生率：ACTIVE W子研究
J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61. doi: 10.1016/j.jacc.2007.07.076. Epub 2007 Nov 13.

引用本文的文献

1
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis.直接口服抗凝剂与华法林在低体重房颤患者中的比较有效性和安全性：系统评价和荟萃分析。
Am J Cardiovasc Drugs. 2024 Mar;24(2):255-271. doi: 10.1007/s40256-024-00628-6. Epub 2024 Feb 22.
2
Challenges of Anticoagulant Therapy in Atrial Fibrillation-Focus on Gastrointestinal Bleeding.房颤抗凝治疗面临的挑战-关注胃肠道出血。
Int J Mol Sci. 2023 Apr 7;24(8):6879. doi: 10.3390/ijms24086879.
3
Stroke Prophylaxis for Atrial Fibrillation? To Prescribe or Not to Prescribe-A Qualitative Study on the Decisionmaking Process of Emergency Department Providers.
心房颤动的卒中预防？开还是不开处方——对急诊科提供者决策过程的定性研究。
Ann Emerg Med. 2019 Dec;74(6):759-771. doi: 10.1016/j.annemergmed.2019.03.026. Epub 2019 May 9.
4
Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes.普拉格雷在常规实践中的应用：瑞蒙德联合心脏病学研究（CCR）在急性冠脉综合征经皮冠状动脉介入治疗中的原理和设计。
Neth Heart J. 2014 Feb;22(2):55-61. doi: 10.1007/s12471-013-0472-1.
5
Oral antiplatelet therapy in acute coronary syndromes: update 2012.急性冠状动脉综合征的口服抗血小板治疗：2012 年更新。
Eur Heart J Acute Cardiovasc Care. 2012 Apr;1(1):79-86. doi: 10.1177/2048872612443345.
6
Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study.华法林抗凝治疗期间的脑出血：一项连续观察性研究。
J Neurol. 2013 Aug;260(8):2046-51. doi: 10.1007/s00415-013-6939-6. Epub 2013 May 5.
7
Atrial fibrillation: its prevalence and risk factor profile in the German general population.心房颤动：德国普通人群中的患病率及其危险因素特征。
Dtsch Arztebl Int. 2012 Apr;109(16):293-9. doi: 10.3238/arztebl.2012.0293. Epub 2012 Apr 20.
8
Can we predict stroke in atrial fibrillation?我们能否预测房颤中的脑卒中？
Clin Cardiol. 2012 Jan;35 Suppl 1(Suppl 1):21-7. doi: 10.1002/clc.20969.
9
Atrial fibrillation and vascular disease--a bad combination.心房颤动与血管疾病——不良组合。
Clin Cardiol. 2012 Jan;35 Suppl 1(Suppl 1):15-20. doi: 10.1002/clc.20955.
10
Are family physicians using the CHADS₂score? Is it useful for assessing risk of stroke in patients with atrial fibrillation?家庭医生是否在使用 CHADS₂评分？对于评估房颤患者的中风风险，它是否有用？
Can Fam Physician. 2011 Aug;57(8):e305-9.